Christopher S Johns
Overview
Explore the profile of Christopher S Johns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goh Z, Johns C, Julius T, Barnes S, Dwivedi K, Elliot C, et al.
Wellcome Open Res
. 2024 Aug;
6:249.
PMID: 39113847
Background: Computed tomography pulmonary angiography (CTPA) has been proposed to be diagnostic for pulmonary hypertension (PH) in multiple studies. However, the utility of the unenhanced CT measurements diagnosing PH has...
2.
Lanham S, Maiter A, Swift A, Dwivedi K, Alabed S, Evans O, et al.
BJR Open
. 2024 Mar;
4(1):20220041.
PMID: 38495814
Objectives: Right ventricular (RV) dysfunction carries elevated risk in acute pulmonary embolism (PE). An increased ratio between the size of the right and left ventricles (RV/LV ratio) is a biomarker...
3.
Matthews S, Kyi M, Nasimudeen A, Marusic A, Johns C, Page J
Br J Radiol
. 2024 Jan;
97(1154):371-376.
PMID: 38268227
Objective: The introduction of Targeted Lung Health Checks (TLHC) to screen for lung cancer has highlighted that incidental findings are common and require management strategies. This study analyses retrospectively, incidentally...
4.
Chan H, Weatherley N, Biancardi A, Johns C, Tahir B, Karwoski R, et al.
Diagnostics (Basel)
. 2023 Dec;
13(23).
PMID: 38066737
The patterns of idiopathic pulmonary fibrosis (IPF) lung disease that directly correspond to elevated hyperpolarised gas diffusion-weighted (DW) MRI metrics are currently unknown. This study aims to develop a spatial...
5.
Maiter A, Hocking K, Matthews S, Taylor J, Sharkey M, Metherall P, et al.
BMJ Open
. 2023 Nov;
13(11):e077348.
PMID: 37940155
Objectives: Early identification of lung cancer on chest radiographs improves patient outcomes. Artificial intelligence (AI) tools may increase diagnostic accuracy and streamline this pathway. This study evaluated the performance of...
6.
Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K, et al.
Eur Respir J
. 2023 Jul;
62(2).
PMID: 37414419
Background: Cardiac magnetic resonance (CMR) is the gold standard technique to assess biventricular volumes and function, and is increasingly being considered as an end-point in clinical studies. Currently, with the...
7.
Alabed S, Uthoff J, Zhou S, Garg P, Dwivedi K, Alandejani F, et al.
Eur Heart J Digit Health
. 2023 Jan;
3(2):265-275.
PMID: 36713008
Aims: Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features...
8.
Sharkey M, Taylor J, Alabed S, Dwivedi K, Karunasaagarar K, Johns C, et al.
Front Cardiovasc Med
. 2022 Oct;
9:983859.
PMID: 36225963
Introduction: Computed tomography pulmonary angiography (CTPA) is an essential test in the work-up of suspected pulmonary vascular disease including pulmonary hypertension and pulmonary embolism. Cardiac and great vessel assessments on...
9.
Goh Z, Balasubramanian N, Alabed S, Dwivedi K, Shahin Y, Rothman A, et al.
Heart
. 2022 May;
108(17):1392-1400.
PMID: 35512982
Objectives: To determine the prognostic value of patterns of right ventricular adaptation in patients with pulmonary arterial hypertension (PAH), assessed using cardiac magnetic resonance (CMR) imaging at baseline and follow-up....
10.
Alandejani F, Hameed A, Tubman E, Alabed S, Shahin Y, Lewis R, et al.
Front Cardiovasc Med
. 2022 Apr;
9:797561.
PMID: 35402574
Background: Current European Society of Cardiology and European Respiratory Society guidelines recommend regular risk stratification with an aim of treating patients with pulmonary arterial hypertension (PAH) to improve or maintain...